Details of the Drug

General Information of Drug (ID: DMZNGJL)

• Drug Name: Cintredekin besudotox

Indication

Disease Entry	ICD 11	Status	REF
Brain cancer	2A00	Phase 3	[1]

• Affected Organisms: Humans and other mammals
• Cross-matching ID:
  UNII: ZL04JX89M7
  DrugBank ID: DB05305
  TTD ID: D0G6RB

References

• [1] ClinicalTrials.gov (NCT00076986) The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme. U.S. National Institutes of Health.